These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 33122069)
1. Rod-shaped polypeptide nanoparticles for siRNA delivery. Li D; Li X; Bai J; Liu Y; de Vries R; Li Y Int J Biol Macromol; 2021 Jan; 166():401-408. PubMed ID: 33122069 [TBL] [Abstract][Full Text] [Related]
2. Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform. Shi M; Zhang J; Huang Z; Chen Y; Pan S; Hu H; Qiao M; Chen D; Zhao X J Mater Chem B; 2020 Feb; 8(8):1616-1628. PubMed ID: 32010914 [TBL] [Abstract][Full Text] [Related]
3. Folate-Mediated Targeted Delivery of siPLK1 by Leucine-Bearing Polyethylenimine. Hou L; Song Z; Xu Z; Wu Y; Shi W Int J Nanomedicine; 2020; 15():1397-1408. PubMed ID: 32184594 [TBL] [Abstract][Full Text] [Related]
4. Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer. Mahajan UM; Teller S; Sendler M; Palankar R; van den Brandt C; Schwaiger T; Kühn JP; Ribback S; Glöckl G; Evert M; Weitschies W; Hosten N; Dombrowski F; Delcea M; Weiss FU; Lerch MM; Mayerle J Gut; 2016 Nov; 65(11):1838-1849. PubMed ID: 27196585 [TBL] [Abstract][Full Text] [Related]
5. Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment. Bulbake U; Kommineni N; Ionov M; Bryszewska M; Khan W Pharm Dev Technol; 2020 Jan; 25(1):9-19. PubMed ID: 30633621 [TBL] [Abstract][Full Text] [Related]
6. SiRNA-phospholipid conjugates for gene and drug delivery in cancer treatment. Liu H; Li Y; Mozhi A; Zhang L; Liu Y; Xu X; Xing J; Liang X; Ma G; Yang J; Zhang X Biomaterials; 2014 Aug; 35(24):6519-33. PubMed ID: 24797882 [TBL] [Abstract][Full Text] [Related]
7. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer. Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820 [TBL] [Abstract][Full Text] [Related]
8. Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles. Zhao J; Mi Y; Feng SS Biomaterials; 2013 Apr; 34(13):3411-21. PubMed ID: 23375951 [TBL] [Abstract][Full Text] [Related]
9. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy. Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126 [TBL] [Abstract][Full Text] [Related]
10. Design of Cationic Multiwalled Carbon Nanotubes as Efficient siRNA Vectors for Lung Cancer Xenograft Eradication. Guo C; Al-Jamal WT; Toma FM; Bianco A; Prato M; Al-Jamal KT; Kostarelos K Bioconjug Chem; 2015 Jul; 26(7):1370-9. PubMed ID: 26036843 [TBL] [Abstract][Full Text] [Related]
11. The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle. Liu DZ; Cheng Y; Cai RQ; Wang Bd WW; Cui H; Liu M; Zhang BL; Mei QB; Zhou SY Nanomedicine; 2018 Apr; 14(3):991-1003. PubMed ID: 29339188 [TBL] [Abstract][Full Text] [Related]
12. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy. Li Y; Liu R; Yang J; Ma G; Zhang Z; Zhang X Biomaterials; 2014 Dec; 35(36):9731-45. PubMed ID: 25189519 [TBL] [Abstract][Full Text] [Related]
13. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma. Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer. McCarroll JA; Dwarte T; Baigude H; Dang J; Yang L; Erlich RB; Kimpton K; Teo J; Sagnella SM; Akerfeldt MC; Liu J; Phillips PA; Rana TM; Kavallaris M Oncotarget; 2015 May; 6(14):12020-34. PubMed ID: 25557168 [TBL] [Abstract][Full Text] [Related]
15. Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer. Okamoto A; Asai T; Hirai Y; Shimizu K; Koide H; Minamino T; Oku N Mol Pharm; 2018 Apr; 15(4):1495-1504. PubMed ID: 29502423 [TBL] [Abstract][Full Text] [Related]
16. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy. Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952 [TBL] [Abstract][Full Text] [Related]
17. Design of Peptidomimetic Functionalized Cholesterol Based Lipid Nanoparticles for Efficient Delivery of Therapeutic Nucleic Acids. Ehexige E; Ganbold T; Yu X; Han S; Baigude H Molecules; 2019 Sep; 24(18):. PubMed ID: 31546908 [TBL] [Abstract][Full Text] [Related]
18. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy. Liu HM; Zhang YF; Xie YD; Cai YF; Li BY; Li W; Zeng LY; Li YL; Yu RT Int J Nanomedicine; 2017; 12():1065-1083. PubMed ID: 28223799 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. Sun TM; Du JZ; Yao YD; Mao CQ; Dou S; Huang SY; Zhang PZ; Leong KW; Song EW; Wang J ACS Nano; 2011 Feb; 5(2):1483-94. PubMed ID: 21204585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]